Clinical Trial Update: Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and safety of a Hepatitis A vaccine in adults 18-50; sponsor Sinovac Biotech; status Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hepatitis A | Phase 4 | Status: ACTIVE_NOT_RECRUITING